Effects of consumption of structured lipid on the oral environment in healthy Japanese subjects
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-UMIN000052398
- Lead Sponsor
- ORTHOMEDICO Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 68
Not provided
1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" 5. Subjects who are taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products (particularly fish or gelatin) 7. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 8. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 9. Subjects who are judged as ineligible to participate in this study by the physician 10. Subjects who use artificial tooth, post crowns, dentures, implants or bridges 11. Subjects who use floss, interdental brushes, and mouthwash at brushing their teeth 12. Subjects who have undergone dental maintenance such as plaque and tartar removal at a dental clinic within the last 3 months before obtaining consent, or who are planning to undergo maintenance during this trial 13. Subjects who regularly use gargle medicine 14. Subjects with past or present history related to salivary gland disease (such as sialadenitis, sialolithiasis, Sjogren syndrome, or tumor of salivary gland), or who have undergone salivary gland removal 15. Subjects undergoing treatment for dental disease 16. Subjects who are smokers, or started smoking cessation within one year before the agreement to participate in this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment items for periodontal disease
- Secondary Outcome Measures
Name Time Method